Sedation and Guided Education for Depression Study

NCT ID: NCT06705270

Last Updated: 2025-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to understand how patient education surrounding a one-time, consciousness-altering medical intervention impacts the antidepressant response to the intervention in adults with major depressive disorder. In this study, the consciousness-altering medical intervention is a single infusion of propofol, an intravenous anesthetic which might have antidepressant properties.

The main question this study aims to answer is: Does the focus of patient education influence the antidepressant response to a single intravenous infusion of propofol?

Researchers will compare response-focused vs. diagnosis-focused education.

Qualifying participants will:

* Undergo a single intravenous infusion of propofol which will induce a temporary state of sedation
* Wear an EEG cap that records brain activity during sedation
* Be randomized to receive either response-focused or diagnosis-focused education about their brain signals after they recover from sedation
* Be asked to fill out surveys about their mood and other measures of well-being before and after treatment

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder (MDD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Response-focused education

Patient education that is focused on treatment response

Group Type ACTIVE_COMPARATOR

Response-focused education

Intervention Type BEHAVIORAL

Once participants recover from sedation, they will receive education that is focused on their response to treatment.

Diagnosis-focused education

Patient education that is focused on the diagnosis of major depressive disorder

Group Type ACTIVE_COMPARATOR

Diagnosis-focused education

Intervention Type BEHAVIORAL

Once participants recover from sedation, they will be provided education that is focused on their diagnosis of major depressive disorder.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Response-focused education

Once participants recover from sedation, they will receive education that is focused on their response to treatment.

Intervention Type BEHAVIORAL

Diagnosis-focused education

Once participants recover from sedation, they will be provided education that is focused on their diagnosis of major depressive disorder.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of major depressive disorder of at least moderate severity
* Able to read, understand, and provide written informed consent

Exclusion Criteria

* Pregnant or breastfeeding
* Certain substance use disorders
* Daily use of opioids and/or benzodiazepines
* History of psychosis, schizophrenia, or schizoaffective disorder
* Body mass index greater than 35 kg/m2
* Obstructive sleep apnea that is moderate and untreated, or severe
* Any gastrointestinal condition placing the patient at significant risk of aspiration
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Theresa Lii

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Theresa Lii, MD, MS

Role: CONTACT

650-264-9442

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

76737

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment for Post-Stroke Depression
NCT00029172 COMPLETED PHASE4
Antidepressant Effects of Nitrous Oxide
NCT05357040 RECRUITING PHASE2
Precision Care for Major Depressive Disorder
NCT06580041 ENROLLING_BY_INVITATION PHASE4
Personalized Ultrasonic Brain Stimulation for Depression
NCT05301036 ACTIVE_NOT_RECRUITING PHASE1/PHASE2
Diet and Depression
NCT06252701 COMPLETED NA